Rheumatoid Arthritis News

Certain anti-inflammatory drugs improved antidepressant treatment effects and depression symptoms without increasing risk for adverse events, according to findings from a systematic review and meta-analysis.

CHICAGO — There is a dearth of research evaluating the effects of diet and nutrition on rheumatic immune-mediated inflammatory diseases, and more dietary interventions need to be tested in rigorous clinical trials, according to a presenter at the 2019 Interdisciplinary Autoimmune Summit.

CHICAGO — Although rarely taken into account in practice guidelines, patient satisfaction remains an important factor in both treatment adherence and outcomes for psoriatic and rheumatoid arthritis, according to Jon T. Giles, MD, MPH, of the Columbia University College of Physicians and Surgeons.

One-third of rheumatoid arthritis cases in Appalachia — as well as 20% of arthritis diagnoses overall — among men aged 50 years and older are attributable to coal mining work, according to recent data in Arthritis Care & Research.

Although the incidence of inflammatory arthritis is high among relatives of indigenous North American patients with rheumatoid arthritis, many of these individuals who are autoantibody positive do not ultimately develop inflammatory arthritis, according to data published in Arthritis & Rheumatology.

Primary care patients with inflammatory disease, particularly those with early-onset disease, demonstrate elevated rates of depression and anxiety, according to data published in the Annals of the Rheumatic Diseases.

Although disease burden, as measured by health assessment questionnaires, is similar among patients with osteoarthritis and rheumatoid arthritis at the time of initial visit, those with osteoarthritis demonstrate greater burden scores 6 months later, according to data published in Arthritis & Rheumatology.

Baricitinib demonstrated no association with major adverse cardiovascular or venous thromboembolic events among patients with rheumatoid arthritis, according to a recent meta-analysis published in Arthritis & Rheumatology.

Moderate alcohol consumption has been associated with less severe disease activity in rheumatoid arthritis not because of any benefit of alcohol consumption, but because higher disease activity, disability and poor quality of life often lead to reductions in alcohol use, according to recent findings in Arthritis Care & Research.

A twice daily 5-mg or 10-mg dose of tofacitinib plus methotrexate was associated with improved clinical and radiographic responses between 1 and 2 years among patients with rheumatoid arthritis, with no new safety signals, according to findings published in Arthritis & Rheumatology.